Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients

Clinical trial NCT00086346 · TERMINATED

Trial details

NCT number: NCT00086346
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Liver Transplantation

Start date: 2002-12-01
Primary completion: 2008-07-01
Enrollment: 607

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.